Photodynamic therapy for lung cancer involves the
use of a laser light and photosensitive chemicals to reduce or eliminate
non-small cell lung cancers. The procedure is achieved by injecting the patient
with a photoreactive chemical that accumulates in abnormal cells. Two to three
days later, the area is treated with a laser fit into the lungs, causing the
cells with the chemical to die. This is an experimental non-surgical procedure.
Also
Known As:
- Porfimer
sodium photodynamic therapy for lung cancer
Conditions
Treated with Photodynamic Therapy for Lung Cancer:
Photodynamic therapy for lung cancer may be
performed in cases of non-small cell lung cancer.
There are no comparable non-surgical alternatives to
photodynamic therapy for lung cancer. Surgical alternatives to the procedure
include lobectomy, pneumonectomy, segmentectomy, radiofrequency ablation, brachytherapy
and stereotactic body radiation therapy.
Potential
Complications from Photodynamic Therapy for Lung Cancer:
Possible risks following photodynamic therapy for
lung cancer include infection, bleeding, scarring, swelling, burns, coughing,
chest pain and difficulty swallowing. It is also possible for the
tracheobronchial tree or lungs to be perforated, and to experience severe light
sensitivity for a period of six to eight weeks.
Prognosis
after Photodynamic Therapy for Lung Cancer:
The prognosis for a positive end result following
photodynamic therapy for lung cancer is very good. However, the long term
effects are not well known.
Recovery
from Photodynamic Therapy for Lung Cancer:
Total recovery from photodynamic therapy for lung cancer takes three weeks.
.jpg "Photodynamic Therapy for Lung Cancer")
.jpg "Photodynamic Therapy for Lung Cancer by OrangeCountySurgeons.org (2)")
